Experiments for taxon Caulophyllum robustum (BERBERIDACEAE)

Experiments (40 results)

Filters
Worktypes (21)
14
10
8
6
5
4
3
3
3
3
3
2
2
2
1
1
1
1
1
1
1
No match
Pharmacology (9)
5
2
2
2
2
2
1
1
23
No match
Compounds (16)
12
10
5
4
4
4
4
2
2
2
1
1
1
1
1
5
No match
Organisms (26)
8
4
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
40 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
1171261
ISOLATION AND IDENTIFICATION OF
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE C
1255664
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Caulophyllum robustum (BERBERIDACEAE)
HEDERAGENIN,3-O-(2-BETA-D-GLUCOPYRANOSYL-ALPHA-L-ARABINOPYRANOSYL):HEDERAGENIN,3-O-(ALPHA-L-ARABINOPYRANOSYL):
351077
VOUCHER SPECIMEN REPORTED FOR
Caulophyllum robustum (BERBERIDACEAE)
986274
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN SYNTHESIS INHIBITION
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE C
1171262
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE C
351078
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
986267
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
CYTOTOXIC ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE B
1080835
PMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE G
986273
PHARMACOLOGY OF COMPOUND - IN VITRO
RNA SYNTHESIS INHIBITION
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE C
1252407
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE ACAULOSIDE DCAULOSIDE CCAULOSIDE ECAULOSIDE B
11793
PRESENT IN (REVIEW)
Caulophyllum robustum (BERBERIDACEAE)
LUPANINE
1256333
YIELD IS MORE THAN 100 MGMISOLATION AND IDENTIFICATION OF
Caulophyllum robustum (BERBERIDACEAE)
MAGNOFLORINE
408210
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
CAULOPHYLLOGENIN
1080819
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE GCAULOSIDE ECAULOSIDE F
986268
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA SYNTHESIS INHIBITION
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE B
66012
PRESENT IN (REVIEW)
Caulophyllum robustum (BERBERIDACEAE)
CYTISINE,N-METHYL:
986272
PHARMACOLOGY OF COMPOUND - IN VITRO
DNA SYNTHESIS INHIBITION
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE C
411323
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE GCAULOSIDE DCAULOSIDE ECAULOSIDE F
1117187
ISOLATION AND IDENTIFICATION OF
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE ACAULOSIDE CCAULOSIDE B
986271
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
CYTOTOXIC ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE C
986269
PHARMACOLOGY OF COMPOUND - IN VITRO
RNA SYNTHESIS INHIBITION
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE B
1171263
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE C
41084
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Caulophyllum robustum (BERBERIDACEAE)
TASPINE
325902
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDCHEMICAL CONVERSION OFMASS-SPECTRAL FRAGMENTATION REPORTED
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE A
41085
ISOLATION AND IDENTIFICATION OF
Caulophyllum robustum (BERBERIDACEAE)
CYTISINE,N-METHYL:
351076
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIVIRAL ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
1127576
CMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE CCAULOSIDE B
66011
PRESENT IN (REVIEW)
Caulophyllum robustum (BERBERIDACEAE)
CYTISINE,N-METHYL:
41086
ISOLATION AND IDENTIFICATION OF
Caulophyllum robustum (BERBERIDACEAE)
LUPANINE,(+):TASPINECYTISINE,N-METHYL:
408211
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE B
1171264
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE C
1255366
ISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE ACAULOSIDE GCAULOSIDE DCAULOSIDE ECAULOSIDE B
325901
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTUREENZYMATIC CLEAVAGE OF
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE D
408212
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE C
1255506
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF NEW COMPOUND FOLLOWING ACID HYDROLYSIS
Caulophyllum robustum (BERBERIDACEAE)
CAULOPHYLLOGENIN
986270
PHARMACOLOGY OF COMPOUND - IN VITRO
PROTEIN SYNTHESIS INHIBITION
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE B
614585
PMR SPECTRUM REPORTEDYIELD IS MORE THAN 100 MGMISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE G
608855
PATENT DESCRIBEDPHARMACOLOGY OF EXTRACT - IN HUMANS
SKIN DEPIGMENTATION EFFECT
Caulophyllum robustum (BERBERIDACEAE)
351075
VOUCHER SPECIMEN REPORTED FOR
Caulophyllum robustum (BERBERIDACEAE)
327579
CHEMICAL CONVERSION OFMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Caulophyllum robustum (BERBERIDACEAE)
CAULOSIDE B